Stengone Carmine N.

Director, Officer at CTNM

Sold, on record
$401k
Dollars the filings state
Form 4 sales
6
Latest Sep 8, 2026
Form 144 notices
5
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CTNMContineum Therapeutics, Inc.Director, Officer

Sales by reason

6
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. 1 Form 144 notice CTNMNotice
    Jun 30, 2026 2026

    Filed to sell 10,000 shares ($150k)

    Stengone Carmine N., Director, Officer

    10b5-1 planFiling

  2. 2 Form 4 sale CTNMRoutine
    Jun 30, 2026 same day

    Sold 10,000 shares at $16.01 ($160k)

    Stengone Carmine N., CEO and President

    10b5-1 planSold 36.7% of holdings ($436k position)17,217 shares leftFollows a Form 144Filing

  3. 3 Form 144 notice CTNMNotice
    Jul 8, 2026 +8 days

    Filed to sell 2,500 shares ($36k)

    Stengone Carmine N., Director, Officer

    10b5-1 plan0.4x usual sizeFiling

  4. 4 Form 4 sale CTNMRoutine
    Jul 8, 2026 same day

    Sold 2,500 shares at $16.00 ($40k)

    Stengone Carmine N., CEO and President

    10b5-1 planSold 12.7% of holdings ($315k position)17,217 shares left0.4x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice CTNMNotice
    Aug 3, 2026 +26 days

    Filed to sell 2,500 shares ($39k)

    Stengone Carmine N., Director, Officer

    10b5-1 plan0.5x usual sizeFiling

  6. 6 Form 4 sale CTNMRoutine
    Aug 3, 2026 same day

    Sold 2,500 shares at $16.01 ($40k)

    Stengone Carmine N., CEO and President

    10b5-1 planSold 12.7% of holdings ($316k position)17,217 shares left0.5x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice CTNMNotice
    Sep 8, 2026 +36 days

    Filed to sell 2,500 shares ($42k)

    Stengone Carmine N., Director, Officer

    10b5-1 plan1x usual sizeFiling

  8. 8 Form 4 sale CTNMRoutine
    Sep 8, 2026 same day

    Sold 2,500 shares at $16.46 ($41k)

    Stengone Carmine N., CEO and President

    10b5-1 planSold 12.7% of holdings ($325k position)17,217 shares left1x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Stengone Carmine N.
Source
Sep 8, 2026Sep 8, 2026CTNMCEO and PresidentForm 4 sale2,500$41k12.7%RoutineSEC
Sep 8, 2026Sep 8, 2026CTNMDirector, OfficerForm 144 notice2,500$42kNoticeSEC
Aug 3, 2026Aug 3, 2026CTNMCEO and PresidentForm 4 sale2,500$40k12.7%RoutineSEC
Aug 3, 2026Aug 3, 2026CTNMDirector, OfficerForm 144 notice2,500$39kNoticeSEC
Jul 8, 2026Jul 8, 2026CTNMCEO and PresidentForm 4 sale2,500$40k12.7%RoutineSEC
Jul 8, 2026Jul 8, 2026CTNMDirector, OfficerForm 144 notice2,500$36kNoticeSEC
Jun 30, 2026Jul 1, 2026CTNMCEO and PresidentForm 4 sale10,000$160k36.7%RoutineSEC
Jun 30, 2026Jun 30, 2026CTNMDirector, OfficerForm 144 notice10,000$150kNoticeSEC
Feb 25, 2026Feb 26, 2026CTNMCEO and PresidentForm 4 sale7,100$114k32.2%RoutineSEC
Feb 11, 2026Feb 13, 2026CTNMCEO and PresidentForm 4 sale400$6k2.6%RoutineSEC
Feb 11, 2026Feb 11, 2026CTNMDirector, OfficerForm 144 notice7,500$118kNoticeSEC